BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 25907141)

  • 1. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
    J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
    Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
    Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
    J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation after ex vivo lung perfusion: A midterm follow-up.
    Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
    J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation.
    Tikkanen JM; Cypel M; Machuca TN; Azad S; Binnie M; Chow CW; Chaparro C; Hutcheon M; Yasufuku K; de Perrot M; Pierre AF; Waddell TK; Keshavjee S; Singer LG
    J Heart Lung Transplant; 2015 Apr; 34(4):547-56. PubMed ID: 25476845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
    Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
    J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study.
    Wallinder A; Ricksten SE; Silverborn M; Hansson C; Riise GC; Liden H; Jeppsson A; Dellgren G
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):40-4; discussion 44-5. PubMed ID: 23666375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Criteria for Ex Vivo Lung Perfusion Have No Significant Impact on Posttransplant Outcomes.
    Okahara S; Levvey B; McDonald M; D'Costa R; Opdam H; Pilcher DV; Snell GI
    Ann Thorac Surg; 2021 Apr; 111(4):1156-1163. PubMed ID: 32890490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the first 50 ex vivo lung perfusions in clinical transplantation.
    Cypel M; Yeung JC; Machuca T; Chen M; Singer LG; Yasufuku K; de Perrot M; Pierre A; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1200-6. PubMed ID: 22944089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo lung perfusion allows successful transplantation of donor lungs from hanging victims.
    Bennett DT; Reece TB; Smith PD; Grandhi MS; Rove JA; Justison GA; Mitchell JD; Fullerton DA; Zamora MR; Weyant MJ
    Ann Thorac Surg; 2014 Sep; 98(3):1051-6. PubMed ID: 25038007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ex vivo lung perfusion at a centralized evaluation facility.
    Mallea JM; Hartwig MG; Keller CA; Kon Z; Iii RNP; Erasmus DB; Roberts M; Patzlaff NE; Johnson D; Sanchez PG; D'Cunha J; Brown AW; Dilling DF; McCurry K
    J Heart Lung Transplant; 2022 Dec; 41(12):1700-1711. PubMed ID: 36229329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
    Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin administration during ex vivo lung perfusion ameliorates lung ischemia-reperfusion injury.
    Motoyama H; Chen F; Hijiya K; Kondo T; Ohsumi A; Yamada T; Sato M; Aoyama A; Bando T; Date H
    J Heart Lung Transplant; 2014 Oct; 33(10):1093-9. PubMed ID: 25043623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconditioning of lungs donated after circulatory death with normothermic ex vivo lung perfusion.
    Nakajima D; Chen F; Yamada T; Sakamoto J; Ohsumi A; Bando T; Date H
    J Heart Lung Transplant; 2012 Feb; 31(2):187-93. PubMed ID: 22305381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-center experience of ex vivo lung perfusion and subsequent lung transplantation.
    Noda K; Chan EG; Furukawa M; Ryan JP; Clifford S; Luketich JD; Sanchez PG;
    Clin Transplant; 2023 Feb; 37(2):e14901. PubMed ID: 36588340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion.
    Medeiros IL; Pêgo-Fernandes PM; Mariani AW; Fernandes FG; do Vale Unterpertinger F; Canzian M; Jatene FB
    J Heart Lung Transplant; 2012 Mar; 31(3):305-9. PubMed ID: 22133788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.